About me

Prof. Aleix Prat is currently the Head of the Medical Oncology Department of Hospital Clínic Barcelona (Spain), Tenure-Track Professor of the University of Barcelona and the Head of the Translational Genomics and Targeted Therapeutics in Solid Tumors Group at August Pi i Sunyer Biomedical Research Institute (IDIBAPS). He obtained his MD degree in 2003 from the University of Barcelona and completed a medical oncology fellowship in 2008 at Vall d´Hebron Institute of Oncology (VHIO). In 2008, Dr. Prat became a postdoctoral research associate at the Lineberger Comprehensive Cancer Center (University of North Carolina at Chapel Hill, USA) in the Laboratory of Prof. Charles M. Perou. In 2012, he

Featured publications

Featured Projects

  • AACR 2019 - Tailoring systemic treatment of Luminal B breast cancer

    Principal investigator: Aleix Prat Aparicio
    Funder: Institut d`Investigacions Biomèdiques August Pi i Sunyer (Sede); Breast Cancer Research Foundation-AACR Career Development Awards for Translational Breast Cancer Research
    Code: BCRF_AACR_18_001
    Duration: 01/07/2019 - 30/06/2021
  • Prospective exploratory study for determination of circulating tumor DNA (ctDNA) in blood samples from patients treated for breast cancer in follow-up and without evidence of relapse (B-CRONOS) KEYWORDS : Breast cancer, ctDNA, luminal, high risk

    Principal investigator: Aleix Prat Aparicio
    Funder: Institut d`Investigacions Biomèdiques August Pi i Sunyer (Sede); Fundación Quiron Salaud ; Fundación Quirón Salud
    Code: TERAPIA_AMIGOS_18_01
    Duration: 11/02/2019 - 10/02/2022
  • Targeting the HER2-enriched phenotype in hormone receptor-positive breast cancer  

    Principal investigator: Aleix Prat Aparicio
    Code: 2018NOVPCC1294
    Duration: 01/02/2019 - 31/01/2022
  • Estudio prospectivo exploratorio para la determinación de DNA circulante tumoral (ctDNA) en muestras sanguíneas de pacientes tratadas por cáncer de mama en seguimiento y sin evidencia de recidiva: ESTUDIO B-CRONOS

    Principal investigator: Aleix Prat Aparicio
    Code: AP168952018
    Duration: 15/06/2018 - 14/06/2021
  • AECC 2017 Predictores moleculares de la respuesta al doble bloqueo de HER2 sin quimioterapia en el cancer de mama HER2-positivo

    Principal investigator: Aleix Prat Aparicio
    Duration: 01/11/2017 - 31/12/2019